Rheumatoid arthritis: Anti-TNF and anti-IL-17 antibodies—better together!

Nature Reviews Rheumatology 10, 699 (2014). doi:10.1038/nrrheum.2014.183 Author: Jenny Buckland Combined blockade of TNF and IL-17 could be a therapeutic approach for patients with rheumatoid arthritis (RA) who fail to respond, or who lose responsiveness, to single-cytokine inhibition, according to a paper now published in Arthritis & Rheumatology.Georg Schett and colleagues from the

http://feeds.nature.com/~r/nrrheum/rss/current/~3/j9I7qxT8_dE/nrrheum.2014.183

Source: Nature Reviews Rheumatology - October 28, 2014 Category: Rheumatology Authors: Jenny Buckland Tags: Research Highlight Source Type: research

More News: Arthritis | Rheumatoid Arthritis | Rheumatology